Alejandra Bonilla-Rojas
Family · Brawley, CANPI 1669019618
Payments from drug & device makers
Across 151 payments — averaging $17.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$379
- Novo Nordisk$297
- AstraZeneca$276
- Sanofi-aventis U.S. LLC$198
- Lilly USA, LLC$186
- GSK$172
- plus $1K from 19 others
What the payments were for
- Food & beverage$2,638100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 34 | $379 |
| Novo Nordisk | 19 | $297 |
| AstraZeneca | 15 | $276 |
| Sanofi-aventis U.S. LLC | 14 | $198 |
| Lilly USA, LLC | 10 | $186 |
| GSK | 8 | $172 |
| Amgen | 8 | $167 |
| Corcept Therapeutics | 7 | $148 |
| Merck | 6 | $132 |
| Boehringer Ingelheim | 5 | $107 |
| Bayer | 4 | $87 |
| AbbVie | 3 | $81 |
| Globus Medical | 1 | $65 |
| Pfizer | 3 | $62 |
| Exact Sciences | 2 | $57 |
| Biohaven Pharmaceuticals, Inc. | 2 | $40 |
| Astellas Pharma US Inc | 2 | $30 |
| Amarin Pharma, Inc. | 1 | $23 |
| Esperion Therapeutics, Inc. | 1 | $22 |
| Baxter Healthcare | 1 | $22 |
| Ironwood Pharmaceuticals, Inc | 1 | $22 |
| Novartis | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Redhill Biopharma Inc. | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $12 |
How this compares
$2,638 in reported general payments places this provider in the 85th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 130 | $133,923 |
| OzempicSemaglutide | 114 | $114,474 |
| RybelsusSemaglutide | 58 | $84,847 |
| LinzessLinaclotide | 119 | $81,758 |
| FarxigaDapagliflozin Propanediol | 85 | $76,071 |
| JardianceEmpagliflozin | 66 | $57,738 |
| VascepaIcosapent Ethyl | 105 | $53,710 |
| JanuviaSitagliptin Phosphate | 51 | $49,998 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 54 | $38,570 |
| TrulicityDulaglutide | 34 | $33,589 |
| EliquisApixaban | 27 | $32,693 |
| Icosapent Ethyl | 78 | $23,060 |
| EntrestoSacubitril/Valsartan | 31 | $22,887 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 42 | $19,999 |
| MyrbetriqMirabegron | 32 | $19,919 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $297 | $199,321172 claims |
| Lilly USA, LLCMounjaro, Trulicity | $186 | $167,511164 claims |
| AbbVieLinzess | $81 | $81,758119 claims |
| Boehringer IngelheimJardiance, Tradjenta | $107 | $76,45985 claims |
| AstraZenecaFarxiga | $276 | $76,07185 claims |
| MerckJanuvia, Janumet | $132 | $66,10566 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $198 | $38,57054 claims |
| PfizerEliquis | $62 | $32,69327 claims |
| NovartisEntresto | $19 | $22,88731 claims |
| Astellas Pharma US IncMyrbetriq | $30 | $19,91932 claims |
| Johnson & JohnsonXarelto | $379 | $16,06314 claims |
| GSKTrelegy Ellipta | $172 | $8,68914 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 10,634 family providers in California.
Other family in Brawley
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Jenine StoneEscondido$231K
- Erin DwyerSan Diego$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.